(Q51752513)

11 April 2018

title

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells. (English)

1 reference

11 April 2018

0 references

1 reference

1 reference

Estrella Mariel Levy

1

1 reference

11 April 2018

Gabriela Sycz

2

1 reference

11 April 2018

Juan Martin Arriaga

3

1 reference

11 April 2018

María Marcela Barrio

4

1 reference

11 April 2018

Erika María von Euw

5

1 reference

11 April 2018

Sergio Bayo Morales

6

1 reference

11 April 2018

Mariana González

7

1 reference

11 April 2018

José Mordoh

8

1 reference

11 April 2018

Michele Bianchini

9

1 reference

11 April 2018

publication date

1 April 2009

1 reference

11 April 2018

published in

Innate Immunity

1 reference

11 April 2018

volume

15

1 reference

11 April 2018

issue

2

1 reference

11 April 2018

page(s)

91-100

1 reference

11 April 2018

American Cancer Society guidelines for the early detection of cancer, 2006.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Induction of histone acetylation and inhibition of growth by phenyl alkanoic acids and structurally related molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Clinical results of vaccine therapy for cancer: learning from history for improving the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Recent developments in colorectal cancer treatment by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Follow the leader: NK cell receptors for classical and nonclassical MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Increase in the ratio of mitochondrial Bax/Bcl-XL induces Bax activation in human leukemic K562 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Monoclonal antibodies in therapy of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425908101404

21 January 2018

Identifiers

DOI

10.1177/1753425908101404

1 reference

11 April 2018

PubMed ID

19318419

1 reference

11 April 2018